Literature DB >> 30429216

Neuraminidase 1-mediated desialylation of the mucin 1 ectodomain releases a decoy receptor that protects against Pseudomonas aeruginosa lung infection.

Erik P Lillehoj1, Wei Guang2, Sang W Hyun3,4, Anguo Liu3,4, Nicolas Hegerle3,5, Raphael Simon3,5, Alan S Cross3,5, Hideharu Ishida6, Irina G Luzina3,4, Sergei P Atamas3,4, Simeon E Goldblum3,4,7.   

Abstract

Pseudomonas aeruginosa (Pa) expresses an adhesin, flagellin, that engages the mucin 1 (MUC1) ectodomain (ED) expressed on airway epithelia, increasing association of MUC1-ED with neuraminidase 1 (NEU1) and MUC1-ED desialylation. The MUC1-ED desialylation unmasks both cryptic binding sites for Pa and a protease recognition site, permitting its proteolytic release as a hyperadhesive decoy receptor for Pa. We found here that intranasal administration of Pa strain K (PAK) to BALB/c mice increases MUC1-ED shedding into the bronchoalveolar compartment. MUC1-ED levels increased as early as 12 h, peaked at 24-48 h with a 7.8-fold increase, and decreased by 72 h. The a-type flagellin-expressing PAK strain and the b-type flagellin-expressing PAO1 strain stimulated comparable levels of MUC1-ED shedding. A flagellin-deficient PAK mutant provoked dramatically reduced MUC1-ED shedding compared with the WT strain, and purified flagellin recapitulated the WT effect. In lung tissues, Pa increased association of NEU1 and protective protein/cathepsin A with MUC1-ED in reciprocal co-immunoprecipitation assays and stimulated MUC1-ED desialylation. NEU1-selective sialidase inhibition protected against Pa-induced MUC1-ED desialylation and shedding. In Pa-challenged mice, MUC1-ED-enriched bronchoalveolar lavage fluid (BALF) inhibited flagellin binding and Pa adhesion to human airway epithelia by up to 44% and flagellin-driven motility by >30%. Finally, Pa co-administration with recombinant human MUC1-ED dramatically diminished lung and BALF bacterial burden, proinflammatory cytokine levels, and pulmonary leukostasis and increased 5-day survival from 0% to 75%. We conclude that Pa flagellin provokes NEU1-mediated airway shedding of MUC1-ED, which functions as a decoy receptor protecting against lethal Pa lung infection.

Entities:  

Keywords:  Pseudomonas aeruginosa (P. aeruginosa); adhesin; cell surface associated (MUC1); decoy protein; flagellin; mucin 1; neuraminidase; sialic acid; sialidase; virulence

Mesh:

Substances:

Year:  2018        PMID: 30429216      PMCID: PMC6333888          DOI: 10.1074/jbc.RA118.006022

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  77 in total

Review 1.  Bacterial nanomachines: the flagellum and type III injectisome.

Authors:  Marc Erhardt; Keiichi Namba; Kelly T Hughes
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-10-06       Impact factor: 10.005

Review 2.  Galectins as pattern recognition receptors: structure, function, and evolution.

Authors:  Gerardo R Vasta
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

3.  NEU1 sialidase expressed in human airway epithelia regulates epidermal growth factor receptor (EGFR) and MUC1 protein signaling.

Authors:  Erik P Lillehoj; Sang Won Hyun; Chiguang Feng; Lei Zhang; Anguo Liu; Wei Guang; Chinh Nguyen; Irina G Luzina; Sergei P Atamas; Antonino Passaniti; William S Twaddell; Adam C Puché; Lai-Xi Wang; Alan S Cross; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2012-01-13       Impact factor: 5.157

4.  Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology.

Authors:  Kelli L Palmer; Lauren M Mashburn; Pradeep K Singh; Marvin Whiteley
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

5.  Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding.

Authors:  Amantha Thathiah; Carl P Blobel; Daniel D Carson
Journal:  J Biol Chem       Date:  2002-11-18       Impact factor: 5.157

6.  The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum.

Authors:  Sarah J Storr; Louise Royle; Caroline J Chapman; Umi M Abd Hamid; John F Robertson; Andrea Murray; Raymond A Dwek; Pauline M Rudd
Journal:  Glycobiology       Date:  2008-03-10       Impact factor: 4.313

7.  Electrophoretic separation and molecular weight characterization of Pseudomonas aeruginosa H-antigen flagellins.

Authors:  J S Allison; M Dawson; D Drake; T C Montie
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

8.  Binding of Galectin-3, a β-Galactoside-binding Lectin, to MUC1 Protein Enhances Phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) and Akt, Promoting Tumor Cell Malignancy.

Authors:  Yugo Mori; Kaoru Akita; Masakazu Yashiro; Tetsuji Sawada; Kosei Hirakawa; Takeomi Murata; Hiroshi Nakada
Journal:  J Biol Chem       Date:  2015-09-04       Impact factor: 5.157

9.  New Insights into Molecular Organization of Human Neuraminidase-1: Transmembrane Topology and Dimerization Ability.

Authors:  Pascal Maurice; Stéphanie Baud; Olga V Bocharova; Eduard V Bocharov; Andrey S Kuznetsov; Charlotte Kawecki; Olivier Bocquet; Beatrice Romier; Laetitia Gorisse; Maxime Ghirardi; Laurent Duca; Sébastien Blaise; Laurent Martiny; Manuel Dauchez; Roman G Efremov; Laurent Debelle
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

10.  MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy.

Authors:  Sara K Lindén; Yong H Sheng; Alison L Every; Kim M Miles; Emma C Skoog; Timothy H J Florin; Philip Sutton; Michael A McGuckin
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

View more
  6 in total

1.  Therapeutic Effect of Neuraminidase-1-Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis.

Authors:  Irina G Luzina; Erik P Lillehoj; Virginia Lockatell; Sang W Hyun; Katerina N Lugkey; Akihiro Imamura; Hideharu Ishida; Christopher W Cairo; Sergei P Atamas; Simeon E Goldblum
Journal:  J Pharmacol Exp Ther       Date:  2020-11-02       Impact factor: 4.030

Review 2.  Decoy Technology as a Promising Therapeutic Tool for Atherosclerosis.

Authors:  Maryam Mahjoubin-Tehran; Yong Teng; Amin Jalili; Seyed Hamid Aghaee-Bakhtiari; Alexander M Markin; Amirhossein Sahebkar
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 3.  Defensive Properties of Mucin Glycoproteins during Respiratory Infections-Relevance for SARS-CoV-2.

Authors:  Maitrayee Chatterjee; Jos P M van Putten; Karin Strijbis
Journal:  mBio       Date:  2020-11-12       Impact factor: 7.867

4.  MUC1 ectodomain is a flagellin-targeting decoy receptor and biomarker operative during Pseudomonas aeruginosa lung infection.

Authors:  Avelino C Verceles; Pavan Bhat; Zain Nagaria; Destiny Martin; Harsh Patel; Afua Ntem-Mensah; Sang W Hyun; Andrea Hahn; Jean Jeudy; Alan S Cross; Erik P Lillehoj; Simeon E Goldblum
Journal:  Sci Rep       Date:  2021-11-22       Impact factor: 4.379

5.  Mammalian Neuraminidases in Immune-Mediated Diseases: Mucins and Beyond.

Authors:  Erik P Lillehoj; Irina G Luzina; Sergei P Atamas
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

6.  Burkholderia cenocepacia-host cell contact controls the transcription activity of the trimeric autotransporter adhesin BCAM2418 gene.

Authors:  Andreia I Pimenta; Dalila Mil-Homens; Arsenio M Fialho
Journal:  Microbiologyopen       Date:  2020-02-25       Impact factor: 3.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.